Purchase Order 36C26122P1344
Award Date 7/6/22
Potential Completion Date 9/30/22
Potential Value $81K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Palo Alto, CA 94304, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 21 to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, for the delivery of the specialty pharmaceutical Tyvaso. The total ceiling value of the contract is $81,342.18, with a period of performance through September 30, 2022. Accredo Health Group, Inc. is a key distributor of complex and high-value medications, primarily serving the...
- This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract, valued at $94,899.21, is for the delivery of the drug Tyvaso, which is used to treat pulmonary arterial hypertension. The contract is not associated with a larger contract vehicle and does not have a set-aside designation. Accredo Health Group, Inc. is the prime contractor and there are no major...
- This is a $93,341.96 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the specialty pharmaceutical Tyvaso, which is used to treat pulmonary arterial hypertension. This contract is part of Accredo Health Group's ongoing work supporting the VA's Veterans Integrated Service Network (VISN) 21 with the distribution of specialty medications. The...
- This is a $113,770.56 firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the delivery of TYVASCO 0.6 MG, a specialty pharmaceutical product, to support veterans' healthcare through the VA's Veterans Integrated Service Network 21. The contract does not have a set-aside designation and will be performed at Accredo's...
- The U.S. Department of Veterans Affairs (VA) awarded a $43,162 firm fixed-price purchase order to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide the specialty pharmaceutical Prolastin. This contract is not associated with a set-aside program and has an ultimate completion date of June 30, 2024. Accredo Health Group, Inc., a subsidiary of Express Scripts, is a key distributor of complex and high-value medications, primarily serving the healthcare needs of...
- This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company that specializes in specialty pharmaceutical services. The contract, valued at $75,576.09, is for the delivery of Uptravi medicine to support the VA's Veterans Integrated Service Network (VISN) 6. The contract does not have a set-aside designation and was awarded on October 27, 2020, with a completion date of...
- This is a $103,003.20 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company specializing in specialty pharmaceutical services. The contract is for the delivery of various complex and high-value medications, primarily to support the VA's Veterans Integrated Service Network (VISN) healthcare facilities. Key medications provided under this contract include drugs used to treat...
- The Department of Veterans Affairs Veterans Health Administration awarded a $13,557 purchase order to Accredo Health Group, Inc. to deliver TYVASO in Palo Alto, California from January 18, 2023 through April 18, 2023. As a prime contractor supporting VA's Veterans Integrated Service Network 21, Accredo Health Group will provide the pulmonary arterial hypertension medication on a firm fixed price basis. No subcontractors or set aside designations were indicated. This purchase order was issued...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit specialty pharmacy company. The contract is for a 180-day supply of the medication Uptravi 600mcg, with a ceiling value of $78,557.34. The contract is not designated as a set-aside. Accredo Health Group, Inc. is a key distributor of complex and high-value medications to the VA's Veterans Integrated Service Networks (VISNs), with a focus on drugs...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company specializing in specialty pharmaceutical services. The contract, valued at $160,429.83, is for the delivery of the medication Uptravi 1600mcg, which is used to treat pulmonary arterial hypertension (PAH). The contract is part of the VA's efforts to provide critical medications to veterans through its Veterans...